Med-El loses UK appeal in Advanced Bionics fight

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

Med-El loses UK appeal in Advanced Bionics fight

Entrance to the Royal Court of Justice

The Court of Appeal had stern words for Med-El’s representatives after they highlighted a deputy judge’s background as a solicitor

Hearing implant maker Med-El lost an appeal in its patent fight with Advanced Bionics at the England and Wales Court of Appeal today, May 24.

Lady Justice Kathryn Thirlwall, who handed down the judgment, also had sharp words for Med-El’s representatives over a reference to a deputy High Court judge’s background as a solicitor.

Med-El had challenged the High Court’s decision, issued by Mr Justice Campbell Forsyth in June 2022, to invalidate one of its patents covering cochlear implants.

Arguments began yesterday, May 23, and finished this morning.

The court, which dismissed Med-El’s appeal in full, handed down its verdict this afternoon.

Thirlwall heard the appeal alongside Lord Justices Richard Arnold and Colin Birss.

The full judgment has yet to be published, but Managing IP attended a virtual hand down.

According to Med-El’s counsel, Forsyth made an error in finding the patent obvious over a piece of prior art.

The prior art in question was another patent covering the design of cochlear implants and referred to as ‘Zimmerling’.

Sharp rebuke

At the end of proceedings, Thirlwall criticised Med-El’s representatives over how they referred to Forsyth in their skeleton argument.

The document referred to Forsyth’s job as a partner at Mishcon de Reya and noted that he was appointed to sit as a deputy High Court judge in late 2021.

Thirlwall said these details were irrelevant and “raised eyebrows” among the judges.

“Those matters shouldn’t have been in the skeleton argument.

“It’s no more appealing to do that than to say it was a very strong court,” she told Adrian Speck KC, who argued for Med-El.

Speck said the brief was only meant to identify the judge.

But Thirlwall replied: “His name would have done, and we had that on the judgment.

“I wouldn’t expect to see that sort of observation made in anyone’s skeletons before this court.”

In its own skeleton, Advanced Bionics criticised Med-El for highlighting Forsyth’s training as a solicitor.

“They could also have pointed out that he is a patent specialist of many years’ standing,” the Advanced Bionics brief said.

Solicitor judges are rare in England and Wales, where most High Court judges are former barristers.

An EPO board of appeal upheld an amended version of Med-El’s patent last September.

more from across site and SHARED ros bottom lb

More from across our site

The firm reveals how its litigation strategies informed the arguments that took Masimo’s judgment past $818 million
The firm was rebuilding its IP practice through a string of patent hires and a Texas expansion, but its dissolution has put the newly built talent back into the market
AI can exploit longstanding gaps in copyright protection at remarkable speed, but EU law still provides tools to fight back, says Simon Hembt at Bird & Bird
The firm has tapped a local patent trio to establish a foothold in the market and broaden its national presence
New Asia-Pacific IP head Jonathan Chu is eyeing opportunities arising from Chinese technology licensing, overseas enforcement and increasingly IP-heavy cross-border deals
Europe’s largest intellectual property convention and trade fair is back: IP Service World 2026 takes place in Munich from November 23–25 – the 16th edition, with 1,400-plus attendees from 55-plus nations, 100-plus speakers, and 100-plus exhibitors. Three days. Two focused areas. One IP marketplace.
Mehmet Gün and Uğur Aktekin discuss four decades of change in Türkiye’s legal market, the firm’s commitment to independence and the challenge of building an institution that can outlast its founders
Boehringer Ingelheim has instructed a team from Kirkland, while Teva is being represented by Pinsent Masons
The Delhi High Court’s latest directions offer an opportunity to move beyond remedies against bad-faith registrations and address how suspicious applications are identified in the first place, says Fatima Baig at Lexlinc
Camilla Hamrin describes how the acquisition by Acapo Onsagers will impact Bergenstråhle’s trademark practice – and reflects on changes she has seen over 30 years in IP
Gift this article